Analyst Price Targets — LFVN
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| August 28, 2026 12:51 pm | Ryan Meyers | Lake Street | $6.00 | $6.19 | TheFly | LifeVantage price target raised to $6 from $5 at Lake Street |
| February 5, 2026 1:47 pm | Brooks O'Neil | Loop Capital Markets | $5.00 | $4.54 | StreetInsider | Lifevantage Corporation (LFVN) PT Lowered to $5 at Lake Street Capital Markets |
| February 5, 2026 1:45 pm | — | Lake Street | $5.00 | $4.60 | TheFly | LifeVantage price target lowered to $5 from $12 at Lake Street |
| November 5, 2025 2:10 pm | Ryan Meyers | Lake Street | $12.00 | $7.03 | TheFly | LifeVantage price target lowered to $12 from $30 at Lake Street |
| January 14, 2025 12:42 pm | Alex Fuhrman | Craig-Hallum | $35.00 | $16.45 | TheFly | LifeVantage initiated with a Buy at Craig-Hallum |
| January 10, 2025 1:44 pm | Brooks O'Neil | Lake Street | $30.00 | $22.52 | TheFly | LifeVantage price target raised to $30 from $26 at Lake Street |
| December 19, 2024 1:17 pm | Brooks O'Neil | Lake Street | $26.00 | $14.60 | TheFly | LifeVantage initiated with a Buy at Lake Street |
Latest News for LFVN
LifeVantage Corporation (LFVN) Q4 2026 Earnings Call Transcript
Lifevantage NASDAQ: LFVN reported lower fourth-quarter and fiscal 2026 results as the health and wellness company faced fewer orders, lower average order sizes and a difficult comparison against prior-year sales of its MindBody GLP-1 System.
SALT LAKE CITY, Aug. 27, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its fourth fiscal quarter ended June 30, 2026.
SALT LAKE CITY, Aug. 21, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that the Company's Board of Directors has approved a quarterly cash dividend of $0.050 per share of common stock, which will be paid September 15, 2026 to all stockholders of record at the…
SALT LAKE CITY, Aug. 13, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that it will release financial results for its fourth quarter and full fiscal year ended June 30, 2026, after the stock market closes on Thursday, August 27, 2026. The Company will hold a…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for LFVN.
U.S. House Trading
No House trades found for LFVN.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.